Trulieve Cannabis Corp(TRLV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 5:05 PM ET (Korea 9/12 06:05)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -2.46 | Insider Own | 15.55% | Shs Outstand | 170.0M | Perf Week | -5.67% |
| Market Cap | 2.18B | Forward P/E | 19.67 | EPS next Y | 131.56% | Insider Trans | -5.37% | Shs Float | 162.6M | Perf Month | 24.15% |
| Enterprise Value | 2.43B | PEG | - | EPS next Q | 0.09 | Inst Own | 17.74% | Short Float | 0.89% | Perf Quarter | -2.08% |
| Income | -0.47B | P/S | 1.91 | EPS this Y | -198.69% | Inst Trans | 25.01% | Short Ratio | 1.05 | Perf Half Y | 83.31% |
| Sales | 1.14B | P/B | 2.84 | EPS next 5Y | - | ROA | -18.72% | Short Interest | 1.44M | Perf YTD | 30.15% |
| Book/sh | 3.99 | P/C | 6.69 | EPS past 3/5Y | 22.54% - | ROE | -46.96% | 52W High | -14.83% ($13.28) | Perf Year | 59.97% |
| Cash/sh | 1.69 | P/FCF | 11.29 | Sales past 3/5Y | -1.02% 17.76% | ROIC | -35.9% | 52W Low | 145.02% ($4.62) | Perf 3Y | 57.08% |
| Dividend Est. | - | EV/EBITDA | 7.44 | EPS Y/Y TTM | -177.39% | Gross Margin | 49.43% | Volatility(W/M) | 6.16% 6.31% | Perf 5Y | -55.19% |
| Dividend TTM | - | EV/Sales | 2.13 | Sales Y/Y TTM | -3.9% | Oper. Margin | 13.75% | ATR (14) | 0.67 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.98 | EPS Q/Q | -2821.78% | Profit Margin | -41.55% | RSI (14) | 56.2 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.94 | Sales Q/Q | -10.31% | SMA20 | 1.5% ($11.14) | Beta | 1.8 | Target Price | $18.18 |
| Payout | - | Debt/Eq | 0.75 | Earnings | 2026/8/7 | SMA50 | 16.2% ($9.73) | Rel Volume | 1.09 | Prev Close | $11.32 |
| Employees | 5000 | LT Debt/Eq | 0.72 | EPS/Sales Surpr. | -2544.96% 0.91% | SMA200 | 37.54% ($8.22) | Avg Volume(3M) | 1.38M | Price | $11.31 |
| IPO | 2018/9/27 | Option/Short | Yes/Yes | Trades | 7343 | Volume | 1,504,794 | Change | -0.09% |
Company
TRLV is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🌿 A large-scale cannabis company that operates integrated cultivation, processing, and distribution across major U.S. regions, including Florida. Through its vertically integrated business model and extensive proprietary retail distribution network, it is leading the medical and recreational cannabis markets.
Over the past 1 year, on the higher side
15% below its 1-year high.
TRLV has weak earning power
13.75% of revenue is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -198.7% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +57.1% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 17.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
YOLO 0.13%
MSOS 0.10%It ranks #4 in the industry
Based on market cap of $2B.
TRLV $2B PER -
TAK $58B PER -
TEVA $43B PER 62.4
HLN $40B PER 18.9
FAQ
What kind of company is TRLV?
TRLV belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of TRLV?
The market cap of TRLV is approximately $2.2B, ranking 2,026 within its sector.
What is the 52-week high and low for TRLV?
TRLV has recorded a 52-week high of $13.28 and a low of $4.62.
